chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Chills all day; Headache; injection site pain over 24 hours plus; pain under arm when lifting; Muscle pain; Joint pain; tiredness; This is a spontaneous report received from a contactable consumer, the patient. A 47years-old-male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number ER 8727) via an unspecified route of administration in right arm on 20Mar2021 at 10:00 (at the age of 47 years) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had unspecified allergies to medication, food or other products. The patient had received unspecified medications within 2 weeks of vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 11:00, the patient experienced chills all day, headache which was gone with 3 hours, vaccination site pain over 24 hours plus, pain under arm when lifting, muscle pain, joint pain, tiredness. The patient was not treated with any medication for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of chills, Vaccination site pain, pain in arm, muscle pain, joint pain and tiredness was recovering and for headache it was recovered on the same day.    No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Chills all day; Headache; injection site pain over 24 hours plus; pain under arm when lifting; Muscle pain; Joint pain; tiredness; This is a spontaneous report received from a contactable consumer, the patient. A 47years-old-male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number ER 8727) via an unspecified route of administration in right arm on 20Mar2021 at 10:00 (at the age of 47 years) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had unspecified allergies to medication, food or other products. The patient had received unspecified medications within 2 weeks of vaccination. The patient did not have symptoms associated with COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Mar2021 at 11:00, the patient experienced chills all day, headache which was gone with 3 hours, vaccination site pain over 24 hours plus, pain under arm when lifting, muscle pain, joint pain, tiredness. The patient was not treated with any medication for the events. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of chills, Vaccination site pain, pain in arm, muscle pain, joint pain and tiredness was recovering and for headache it was recovered on the same day.    No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Infection, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Sore arm; Burning sensation; Muscle stiffness; Infection; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: ER8727), via unspecified route of administration in the right arm on 20Mar2021 at 15:15 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included erathema nodosum and allergy. Concomitant medication included birth control (MANUFACTURER UNKNOWN), probiotic (MANUFACTURER UNKNOWN) and multivitamin (MANUFACTURER UNKNOWN) taken for unknown indication from an unknown date. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, patient has not tested for COVID-19. On 21Mar2021 at 00:00, the patient had experienced sore arm, muscle stiffness, burning sensation and infection. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of sore arm, muscle stiffness, burning sensation and infection was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Redness of left arm from vaccination site almost to my elbow.; Swelling of left arm from vaccination site almost to my elbow.; Slight fever; Tiredness; Chills; This is a spontaneous report received from a contactable consumer, the patient. An elderly patient of an unknown aged and gender, received second of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route of administration in left arm on 18Mar2021 at 12:00, as a single dose for COVID-19 immunisation. Medical history included asthma and hypothyroidism. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in left arm on 25Feb2021 at 13:00, as a single dose for COVID-19 immunisation. The patient was allergic to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced slight fever, tiredness and chills on 19Mar2021, redness and swelling of left arm from vaccination site almost to elbow on 20Mar2021. The clinical outcome of slight fever, tiredness, chills, vaccination site swelling and vaccination site erythema was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Oropharyngeal pain, Pyrexia
Clinical narrative: sore throat; fever; felt light headed; This is a spontaneous report received from non-contactable consumer, the patient. A 31-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left deltoid on 19Mar2021 at 11:15 (at the age of 31-years-old), as single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced light headed. On 20Mar2021 at 04:00, the patient experienced fever and sore throat. The patient did not receive any treatment for the adverse events. The adverse events resulted in doctor or other healthcare professional office or clinic visit. The clinical outcome of light headed, fever and sore throat were not resolved at the time of report.  Information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Hypokinesia, Pain in extremity, Spinal pain
Clinical narrative: Felt like had torn muscles in shoulder--intense pain / sudden pain; Limited range of motion, withoutany muscles feeling tense or locked up; Sore arm; Pain and sensation continued to worsen in my arm and shoulder, until it spread to my spine; spine hurt more and more; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6202) via unspecified route of administration in left arm on 17Mar2021 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had not received any other medications in two weeks prior to vaccination. On 18Mar2021, the patient started the morning after vaccine, with just a sore arm (pain in arm). The second day after the vaccine, it felt like the patient had torn muscles in shoulder--intense pain (shoulder pain) and limited range of motion, without any muscles feeling tense or locked up (movements reduced). The third day, pain and sensation continued to worsen in arm and shoulder, until it spread to spine (condition worsened). By the end of the night, arm started to feel okay but spine hurt more and more (pain in spine), feeling like it had a compression injury. It was reported that, the patient that if he had no memory, and someone told he had been in a car accident, or compressed his spine by jumping from 30 feet in the air, he would readily believe it. It was the fourth morning as the patient wrote, and spine still felt same way. No physical activity or other explanation for sudden pain, no prior history of injury/pain for these areas. It was unknown if the patient had received any treatment for the events. The outcome of the events shoulder pain, movements reduced, condition worsened, pain in spine was not resolved and for event pain in arm was resolving at the time of this report.   No follow up attempts are needed. No further information is expected
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Scab, Urticaria
Clinical narrative: Hives all over both arms, whole top half back, face and neck; Has bumpy scabs; Extreme itching; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613), via an unspecified route of administration to the right arm on 16Mar2021 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had no allergies to medications, food, or other products. The patient had not received other vaccines within 4 weeks, prior to the COVID vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration to the right arm on 23Feb2021 at 1530 (at the age of 71-years-old), as a single dose for COVID-19 immunisation. Concomitant medications included colchicine (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN), Lipitor (MANUFACTURER UNKNOWN), Cozaar (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) for an unknown indication. On 23Feb2021 at 2200, the patient experienced hives all over both arms, whole top half back, face and neck, had bumpy scabs and extreme itching. The event resulted in a visit to the doctor or other healthcare professional office/clinic. Since the vaccination, the patient was not tested for COVID-19. Therapeutic measures taken included Benadryl and cortisone cream for the events. The clinical outcome of the events of hives, scab and itching was not recovered at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia, Neck pain
Clinical narrative: Muscle pains in left arm, shoulder and neck; Headache; Shoulder pain; Neck pain; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ENG207), via an unspecified route of administration in the left arm on 11Mar2021 at 18:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and shellfish allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received unspecified medications within 2 weeks of vaccination. The patient previously received aspirin (MANUFACTURER UNKNOWN) and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Mar2021, the patient experienced muscle pains in left arm, shoulder and neck and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events muscle pains in left arm, shoulder and neck and headache. The clinical outcomes of the events muscle pain, headache, shoulder pain and neck pain were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Gait inability, Headache, Pyrexia
Clinical narrative: Lost the ability to walk, could not manage to even get on the potty placed right next to the bed; Developed a headache that remained off and on for 24 hours,  along with a fever of 100.8.; Fever of 100.8; This is a spontaneous report received from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204), via an unspecified route of administration in the left arm on 16Mar2021 at 18:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. The patient was allergic to penicillin, sulfa drugs and avocados. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9267), via an unspecified route in the right arm on 23Feb2021 at 18:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 17Mar2021 at 01:00, the patient developed a headache that remained off and on for 24 hours, along with a fever of 100.8. The fever was treated and broke 8 hours after its initiation, however, prior to that, she had lost her ability to walk. She could not manage to even get on the potty placed right next to her bed, although her husband was trying to lift her. The patient was treated for the event fever and the patient did not any receive any treatment for the events headache and unable to walk. The clinical outcome of the event headache was recovered on 18Mar2021 while that of fever of 100.8 and unable to walk was recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Polymenorrhoea, Premenstrual syndrome
Clinical narrative: Menstrual cycle disrupted; Cramps; Shortened cycle along with serious PMS symptoms.; Unusually heavy period with significantly bad cramps; This is a spontaneous report received from a contactable consumer, the patient. A 43-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9266) via an unspecified route of administration in left arm on 26Feb2021 at 13:15(at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included allergy to bee venom. Concomitant medication included propanol (MANUFACTURER UNKNOWN), multivitamin ( MANUFACTURER UNKNOWN), D (MANUFACTURER UNKNOWN), B12 (MANUFACTURER UNKNOWN), Turmeric and Ging (MANUFACTURER UNKNOWN) all for unknown indications from unknown dates. The patient previously had allergies to medications which included Keflex. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 05Mar2021 the patient experienced disrupted menstrual cycle, shortened cycle along with serious PMS(premenstrual syndrome) symptoms. The patient had unusually heavy period with significantly bad cramps (usually had no cramps). The patient reported that since aging, cycles had been getting longer and less intense. The patient never had PMS like this before. No therapeutic measures were taken as a result of the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event menstrual cycle disrupted, menstrual cramps, heavy periods and PMS was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: Shoulder pain; Mild back pain; Stiffness; Neck pain; This is a spontaneous report received from a contactable patient. A 65-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 18Mar2021 at 09:15 AM (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to erythromycin, eggs, fish/seafood, corn and wheat. The Concomitant medications included tacrolimus (MANUFACTURER UNKNOWN), multivitamin, biotin (MANUFACTURER UNKNOWN), lutein (MANUFACTURER UNKNOWN) and cal ((MANUFACTURER UNKNOWN),) since from unknown dates for unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 11:00 AM, within about 3 hours he began experiencing neck, shoulder, and mid back pain and stiffness. Using constant heat/cold measures, on the fourth day (morning submitting report), the pain was finally going down and stiffness was limited to the neck and shoulder region. The patient felt okay approx (32 hrs after injection). The patient did not receive treatment for the event. The clinical outcome of the event back pain, neck pain and shoulder pain was recovering. No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills; Fever; Aches; Headache; This is a spontaneous report received from a contactable consumer, the patient. A 53-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in right arm on an unspecified date at 07:00 (at the age of 53-years) as a single dose for COVID-19 immunisation. The patient's medical histories were reported as heart disease, appendix out, hernia repair and uvula removed. Concomitant medications included trazodone (MANUFACTURER UNKNOWN), ELIQUIS, LIPITOR, lisinopril (MANUFACTURER UNKNOWN), PLAVIX and CLONAZ. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 12Mar2021 at 19:00, the patient experienced chills, fever, aches, pains and headache. It was reported that the patient experienced these events for three days. The patient did not receive any treatment for these events. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in left arm on 19Mar2021 at 07:15 as a single dose for COVID-19 immunisation. The clinical outcome of chills, fever, aches, pains and headache was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Lymphadenopathy, Pain, Peripheral swelling, Pyrexia
Clinical narrative: body aches and pains; slight fever; greatly enlarged lymph node under right arm, size of an orange; 6 days later; large red swollen area on right arm; very warm to the touch and serious shoulder pain, can hardly lift arm; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6208) via unspecified route of administration in the right arm on 14Mar2021 at 13:30 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic lymphocytic leukaemia (CLL) and fatty liver. The patient had a history of allergy to Percocet. The patient had previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL9266) via unspecified route of administration in the right arm on 21Feb2021 at 15:00 (at the age of 66-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient received medications (unspecified) within 2 weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 14Mar2021 at 16:00, the patient experienced severe body aches and pains, slight fever, greatly enlarged lymph node under right arm, which was in a size of an orange. 06 days later he had large red swollen area in the right arm, also had very warm to the touch and serious shoulder pain where he could hardly lift arm. No therapeutic measures were taken for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe body aches and pains, slight fever, greatly enlarged lymph node under right arm, large red swollen area on right arm, and very warm to the touch and serious shoulder pain, can hardly lift arm were not resolved at the time of this report.   No follow-up attempts possible. No further information expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Fatigue, Feeling abnormal, Hypoaesthesia
Clinical narrative: Back pain; Leg pain; Right knee swelling; foot numbness in both left and right feet; Light headed; Felt odd; Tired; Queasy; Sore Arm; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via unspecified route of administration in right arm on 12Mar2021 at 13:00 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. The medical history included lower back disc surgery on 12Mar2014 was successful but had low level pain on right side and constant slight numbness in right foot 3 small toes and high blood pressure. The patient had no allergies to medications, food, or other products. Concomitant medications included benazepril (MANUFACTURER UNKNOWN) 20 mg daily for high blood pressure. The patient received no other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested positive for COVID-19. On 12Mar2021 at 13:15, the patient felt light headed and felt odd initially after injection. At 1-3 days felt tired , queasy and experienced sore arm. On 15Mar2021, at 3-4 days the patient experienced back pain and leg pain, right knee swelling, foot numbness in both left and right feet  which made the patient difficult to be active and experienced continued same symptoms as day 1-3. At 7-10 days, the patient was mostly back to normal. The patient did not receive any treatment for events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of light headed, feeling abnormal, tiredness, queasy, painful arm, back pain, leg pain, swelling of right knee, numbness in feet was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Joint swelling, Nausea, Pain in extremity
Clinical narrative: Back pain; Leg pain; Right knee swelling; foot numbness in both left and right feet; Light headed; Felt odd; Tired; Queasy; Sore Arm; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207), via unspecified route of administration in right arm on 12Mar2021 at 13:00 (at the age of 65-years-old), as a single dose for COVID-19 immunisation. The medical history included lower back disc surgery on 12Mar2014 was successful but had low level pain on right side and constant slight numbness in right foot 3 small toes and high blood pressure. The patient had no allergies to medications, food, or other products. Concomitant medications included benazepril (MANUFACTURER UNKNOWN) 20 mg daily for high blood pressure. The patient received no other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested positive for COVID-19. On 12Mar2021 at 13:15, the patient felt light headed and felt odd initially after injection. At 1-3 days felt tired , queasy and experienced sore arm. On 15Mar2021, at 3-4 days the patient experienced back pain and leg pain, right knee swelling, foot numbness in both left and right feet  which made the patient difficult to be active and experienced continued same symptoms as day 1-3. At 7-10 days, the patient was mostly back to normal. The patient did not receive any treatment for events. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of light headed, feeling abnormal, tiredness, queasy, painful arm, back pain, leg pain, swelling of right knee, numbness in feet was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Small rash on left under arm; This is a spontaneous report received from a contactable consumer, the patient. A 75-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in left arm on 17Mar2021 at 09:00 (at the age of 75-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and cholesterol. The patient was allergic to talc. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 19Mar2021, the patient had small rash on left under arm. The events not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of adverse event. The clinical outcome of event rash on was not recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Obesity, Oxygen saturation
Clinical narrative: Shortness of breath exacerbated on fast walking but also present on normal walking occasionally; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) as a single dose via unspecified route of administration on 19Mar2021 at 13:00 (at the age of 54-year-old) for COVID-19 immunisation. Medical history included thrombophilia (leiden factors), parotidectomy since 1996 and subsequent regrowth (pleomorphic adenoma- benign), non-Hodgkins lymphoma diagnosed on 14Feb2013, lung scarring from 9/11 exposure and mild seasonal allergy related asthma. It was reported that the patient allergic to mango skin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had obese reading with 75 lbs and pulse rate and oxygen rate (reported as pulsox) 98 or 99 respectively. Concomitant medications included ZYRTEC, baby aspirin (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) and BENEDRYL taken within two weeks of vaccination. On 20Mar2021 at 15:30, the patient experienced shortness of breath exacerbated on fast walking but also present on normal walking occasionally. No treatment was received for the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of event shortness of breath was not resolved at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold-stimulus headache, Nausea, Pain, Pyrexia
Clinical narrative: mild fever; Nausea; Chills; Brain fog; Sleepy; Aches; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613), via an unspecified route of administration in the left arm on 17Mar2021 at 15:45 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, depression, obesity and irritable bowel syndrome with constipation. The patient had known allergy to Dilaudid. Concomitant medications included Losartan (MANUFACTURER UNKNOWN), Duloxetine (MANUFACTURER UNKNOWN), Omeprazole (MANUFACTURER UNKNOWN), Potassium (MANUFACTURER UNKNOWN), Chlorthal (MANUFACTURER UNKNOWN); all for unknown indication, from unknown dates and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 08:00, the patient experienced mild fever, nausea, aches all over, chills, brain fog and sleepy. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.The patient did not receive any treatment for the adverse events. The clinical outcome of the events, mild fever, nausea, aches all over, chills, brain fog and sleepiness were recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: mild fever; Nausea; Chills; Brain fog; Sleepy; Aches; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER2613), via an unspecified route of administration in the left arm on 17Mar2021 at 15:45 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included hypertension, depression, obesity and irritable bowel syndrome with constipation. The patient had known allergy to Dilaudid. Concomitant medications included Losartan (MANUFACTURER UNKNOWN), Duloxetine (MANUFACTURER UNKNOWN), Omeprazole (MANUFACTURER UNKNOWN), Potassium (MANUFACTURER UNKNOWN), Chlorthal (MANUFACTURER UNKNOWN); all for unknown indication, from unknown dates and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 18Mar2021 at 08:00, the patient experienced mild fever, nausea, aches all over, chills, brain fog and sleepy. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.The patient did not receive any treatment for the adverse events. The clinical outcome of the events, mild fever, nausea, aches all over, chills, brain fog and sleepiness were recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Lymphadenopathy
Clinical narrative: Loss of smell; Loss of taste; Slightly swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 60-years old female patient received first dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 20Mar2021 at 16:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergies to sulfur ingredient. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included vyvanse (MANUFACTURER UNKNOWN), dosage 40mg 1xday for unknown indication, omeprazole DR (MANUFACTURER UNKNOWN), dosage 40mg for unknown indication from unknown date. On 21Mar2021 at 08:00 (as reported), patient experienced loss of smell, loss of taste and slightly swollen lymph nodes. The clinical outcome of the events  of loss of smell, loss of taste, slightly swollen lymph nodes were unknown at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Arthralgia, Chills, Fatigue, Myalgia
Clinical narrative: Chills; Muscle and joint aches; Joint aches; Upset stomach; Tired; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 20Mar2021 at 09:15 (at the age of 76-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Allergies to medications, food, or other products that included sulphur drugs. Concomitant medications included Tylenol started on unknown date within 2 weeks of vaccination for unknown indication. The patient previously taken first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the right arm on 27Feb2021 at 09:15 (at the age of 76-years-old) as a single dose for COVID-19 immunisation.  Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received other vaccines within four weeks prior to the COVID-19 vaccine which are not specified. The patient experienced chills, muscle and joint aches, upset stomach and tiredness on 21Mar2021. The patient did not receive any treatment for events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of the events chills, muscle and joint aches, upset stomach and tiredness were not resolved.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Swelling
Clinical narrative: Under arm pain; Noticeable swelling under armpit when palpated; received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via unspecified route of administration in left arm on 05Mar2021 at 18:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior vaccination. The patient received other medications (unspecified) within two weeks of the vaccination. On 09Mar2021 at 08:30, the patient experienced under arm pain that occurred few days after the vaccination, went away and came back, for total of almost two weeks now. The patient noticed swelling under armpit when palpated. The events not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events under arm pain and swelling under armpit when palpated was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pruritus, Viral test
Clinical narrative: Had a headache; mild itchiness.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non- pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; EN6203) via an unspecified route of administration in the Left arm on 11Mar2021 at 15:30 (at the age of 61 years) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, environmental allergies. Concomitant medications included losartan (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN), coq10 (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was tested for COVID-19. On 11Mar2021 at 16:00, the patient experienced headache and had mild itchiness. The headache was for a day but itchiness continued. On 19Mar2021, the patient underwent nasal swab test and result was unknown. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events headache was resolved on 12Mar2021 and itchiness was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pyrexia, Rash, Vaccination site pain
Clinical narrative: Headache; Fever; Chills; injection site soreness; Rash on inside of right thigh. Rash on left side of waist on the back side.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in left arm on 19Mar2021 at 10:30 (61-year-old at the time of vaccination) as a single dose for COVID-19 immunisation. Medical history included cardiac artery disease. The patient had allergy to shrimp. Concomitant medications included atenolol (MANUFACTURE UNKNOWN), PLAVIX and CRESTOR for unknown indications from unknown dates. Patient had not tested positive for COVID-19 since having the vaccine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 01:00, the patient experienced headache, fever, chills, injection site soreness, rash on inside of right thigh and rash on left side of waist on the back side. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, fever, chills, injection site soreness, rash on inside of right thigh and rash on left side of waist on the back side were not recovered.   No follow up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart palpitations; This is a spontaneous report received from a contactable patient. A 41-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ep7534,) via an unspecified route of administration on the left arm on 16Mar2021 at 11:15 AM (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history included beta-thalassemia and chronic migraines. The patient had PCN, latex and shellfish allergy. The concomitant medications included wellbutrin Xl (MANUFACTURERE NKNOWN) 150 mg, zoloft (MANUFACTURER UNKNOWN) 25 mg and magnesium glycin (MANUFACTURER UNKNOWN) from unknown dates for unspecified indication. On 18Mar2021 at 11: 00 AM, the patient experienced event heart palpitations, which began 48 hours after injection and have continued since. The patient did not receive any treatment for the event. The clinical outcome Heart palpitations was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Aphthous ulcer
Clinical narrative: Severe canker sores all over inside of mouth and lips; This is a spontaneous report received from a contactable consumer, the patient. An 80-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via an unspecified route of administration in the right arm on an unknown date as a single dose for COVID-19 immunisation. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: unknown) via an unspecified route of administration in the right arm on 22Feb2021 at 09:30 (at the age of 80 years) as a single dose for COVID-19 immunisation. Medical history included white blood cell count low (recently diagnosed with low white cell under doctor care for that). Concomitant medications included Apixaban (ELIQUIS), amlodipine (MANUFACTURER UNKNOWN), solitol (MANUFACTURER UNKNOWN) Atorvastatin (LIPITOR), multi vitamin (MANUFACTURER UNKNOWN) within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date after the first vaccine the patient experienced severe canker sores all over inside of mouth and lips. The patient did not receive any treatment for the events. The patient stated that severe canker sores all over inside of mouth and lips, highly inflamed swollen area around lips after first shot and now second shot on 24Feb2021, happened two days after each shot. The clinical outcome of the event severe canker sores all over inside of mouth and lips was not resolved at the time of the report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pyrexia
Clinical narrative: severe headaches; Body ache; Extreme body chills; Slight fever; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6205), via an unspecified route of administration in the left arm on 19Mar2021 at 11:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included occasional bronchitis. The patient received unspecified medications within two weeks of COVID-19 vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6205), via an unspecified route of administration in the left arm on 26Feb2021 at 13:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 20Mar2021 at 03:30, the patient experienced severe headaches, extreme body chills, body ache and slight fever. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome for events severe headaches, extreme body chills, body ache and slight fever were recovering at the time of this reporting.   No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Rash
Clinical narrative: Fever (102.7); Rash Left Front forearm; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration on 19Mar2021 at 17:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient was allergic to PEN (penicillin). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration on 26Feb2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Mar2021 at 15:00, the patient had fever (102.7) and experienced rash on left front forearm. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fever (102.7) and rash on left front forearm. The clinical outcomes of the events fever (102.7) and rash on left front forearm were recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.